Zopapogene imadenovec not checked

Precigen, Inc · PRGN-2012

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 4 trial completes
Trials
3 active
3 in total
Targets
 

What this is

How it works
A gene therapy: delivers a gene into the patient's cells so they make a protein they lack.-gene: gene therapy substances WHO name stem
How it’s given
“Zopa will be administered as 4 subcutaneous administrations over a 12-week interval.”In the company’s words, NCT06538480 on ClinicalTrials.gov
Tested for
Recurrent Respiratory Papillomatosis (2 trials), Papillomaviridae (2 trials), Papillomavirus Infections (2 trials), Papillomavirus Infection, Recurrent Respiratory Papillomatosis (RRP), Juvenile-onset Recurrent Respiratory Papillomatosis
Main trialPhase 4
“This open-label study evaluates safety, vector shedding, and retreatment efficacy of Zopapogene imadenovec (Zopa) in adults with recurrent respiratory papillomatosis (RRP). Two cohorts will be enrolled (n=30): Cohort 1 to assess the magnitude and duration of adenoviral vector shedding in urine, feces, skin, and nasal tissue; Cohort 2 to assess the complete response rate following retreatment.”In the company’s words, NCT06538480 on ClinicalTrials.gov
Other names
PRGN-2012

Other drugs for Papillomavirus Infections

All 22 drugs for Papillomavirus Infections

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 4Recruiting 2 Dec 2027 Zopa Retreatment and Vector Shedding in Adults With RRP
Phase 3Not yet recruiting Jan 2029 Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children
Phase 1/2Active, not recruiting 5 Jun 2024 Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Zopapogene imadenovec

Following is part of Solo: you see every change to Zopapogene imadenovec the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in